诱导梅博姆腺功能障碍的药物的现实世界分析:基于FDA不良事件报告系统数据库
Xiang Li1,2,3, Shi-Nan Wu1,2, Si-Qi Zhang4
1Eye Institute & Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Expert opinion on drug safety
|January 3, 2025
概括
这项研究确定了9种可能导致梅博姆腺功能障碍 (MGD) 的药物,这是干眼综合征的常见原因. 调查结果有助于药物安全监测和临床实践,以减少眼睛风险.
科学领域:
- 眼科医生 眼科 眼科
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
背景情况:
- 干眼综合征 (DES) 显著影响患者的生活质量.
- 梅博米腺功能障碍 (MGD) 是DES的主要原因之一,并且可以是阳性产生的.
- 了解药物诱导的MGD对于眼睛健康至关重要.
研究的目的:
- 为了确定与梅博米腺功能障碍 (MGD) 的潜在药物关联.
- 为了分析药物诱导的MGD信号的现实世界数据.
- 为药监和临床实践提供有关眼睛风险的信息.
主要方法:
- 利用了2004年1月至2023年9月的FDA不良事件报告系统 (FAERS) 数据.
- 用于信号检测的使用几率比率 (ROR) 和比例报告比率 (PRR).
- 根据治疗类别对药物进行分类进行分析.
主要成果:
- 分析了289例MGD病例 (平均年龄为51.69岁,65.44%为女性).
- 观察到MGD报告的增加趋势,在2023年达到顶峰.
- 在眼科,瘤学,免疫调节,皮肤学和泌尿器官疗法中确定了9种具有显著MGD关联的药物.
结论:
- 这项研究强调了可能与MGD相关的特定药物.
- 调查结果为持续的药物安全监测提供了宝贵的见解.
- 建议支持优化临床实践,以减轻药物诱导的眼睛风险.
相关概念视频
Pharmacovigilance
730
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
730
Direct-Acting Cholinergic Agonists: Therapeutic Uses
604
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
604
Cholinergic Antagonists: Pharmacokinetics
372
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
372


